Related Experiment Video
Updated: Nov 8, 2025

Author Spotlight: Advancing Research on Candida albicans Biofilm-Associated Prosthetic Joint Infections
Published on: February 2, 2024
Voriconazole-induced periostitis
D C Fernández Ávila1, M Diehl2, A M Degrave2
1Rheumatology Section, Internal Medicine Department, Hospital Italiano de Buenos Aires, Buenos Aires. diana.fernandez@hospitalitaliano.org.ar.
Abstract:
Voriconazole is a fluorinated drug from the triazole group that is widely used in the prophylaxis and treatment of fungal infections in immunosuppressed patients. Chronic use of this medication can generate, as an adverse effect, a multifocal, asymmetric, diffuse and nodular periosteal reaction, associated with severe and disabling skeletal pain and elevated alkaline phosphatase and serum fluoride. Radiography is the imaging technique of choice for periostitis diagnosis. In general, clinical manifestations and radiographic findings disappear, when the drug is discontinued. We report the clinical case of a 44 year-old woman diagnosed with acute myeloid leukemia, who developed an invasive fungal infection treated with voriconazole after a stem cell transplant. Nine months after starting antifungal treatment, she manifested symptoms and radiological signs compatible with periostitis. Due to clinical suspicion, we decided to suspend voriconazole, with consequent resolution of clinical manifestations and radiological findings.
Insights
Chronic voriconazole use can cause periostitis, a painful bone condition, in immunosuppressed patients. Discontinuing the drug typically resolves these adverse effects, as seen in a leukemia patient case.
Area of Science:
- Pharmacology
- Radiology
- Oncology
Background:
- Voriconazole, a triazole antifungal, is crucial for treating fungal infections in immunocompromised individuals.
- Chronic voriconazole therapy can lead to adverse effects, including periostitis, skeletal pain, and elevated alkaline phosphatase and serum fluoride levels.
- Periostitis diagnosis relies on radiography, and symptoms often resolve upon drug cessation.
Observation:
- A 44-year-old female with acute myeloid leukemia developed invasive fungal infection post-stem cell transplant.
- She received voriconazole treatment and subsequently presented with symptoms and radiographic signs of periostitis.
- Clinical manifestations included severe skeletal pain and elevated alkaline phosphatase and serum fluoride levels.
Findings:
- Radiographic imaging confirmed a multifocal, asymmetric, diffuse, and nodular periosteal reaction.
- Discontinuation of voriconazole therapy resulted in the complete resolution of clinical symptoms and radiographic findings.
- This case highlights the diagnostic utility of radiography in identifying drug-induced periostitis.
Implications:
- This case underscores the importance of recognizing voriconazole-induced periostitis as a potential adverse effect.
- Prompt diagnosis and drug withdrawal can lead to favorable patient outcomes and symptom resolution.
- Clinicians should consider voriconazole toxicity in immunocompromised patients presenting with unexplained skeletal pain and periosteal reactions.
More Related Videos
Related Concept Videos
Pericarditis I: Introduction
Endocarditis IV: Nursing Management
Pericarditis IV: Nursing Management
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis I: Introduction
Endocarditis III: Medical Management

